CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Tweedy, Browne Co All Funds (US)Buy1,72812,085$959,066
Q4 2025Olstein Capital ManagementSell-13,00056,000$4,444
Q4 2025Matrix Private Capital GroupBuy1903,980$315,824
Q4 2025Matrix Advisors Value FundSell-26,175$490,048
Q4 2025Ariel Appreciation FundSell-164,554825,092$65,479,301
Q4 2025Hancock Classic ValueSell-263,66515,581,307$1,236,532,523
Q4 2025Cullen Value FundSell-2,1787,569$607,814
Q3 2025Tweedy, Browne Co All Funds (US)Buy5,29610,357$780,814
Q3 2025Dodge & Cox Stock FundSell-112,18073,176,586$5,516,782,819
Q3 2025Olstein Capital ManagementSell-8,00069,000$5,202
Q3 2025Matrix Private Capital GroupSell-7463,790$285,740
Q3 2025Matrix Advisors Value FundSell-516,177$465,684
Q3 2025Sequoia Financial AdvisorsSell-3,16144,569$3,360,090
Q3 2025Hillman Value FundSell-10,63882,359$6,209,045
Q3 2025Renaissance Technologies LLCSell-421,953160,900$12,130,251
Q3 2025Ariel Appreciation FundSell-174,928989,646$74,609,412
Q3 2025Hancock Classic ValueSell-901,88115,844,972$1,194,552,439
Q3 2025Cullen Value FundSell-2,1269,747$755,333
Q2 2025Tweedy, Browne Co All Funds (US)Buy5,0615,061$349,108
Q2 2025Dodge & Cox Stock FundSell-170,35673,288,766$5,055,459,079
Q2 2025Olstein Capital ManagementSell-33,00077,000$5,311
Q2 2025Matrix Private Capital GroupSell-2,3324,536$312,893
Q2 2025Matrix Advisors Value FundBuy536,228$429,607
Q2 2025Turtle Creek Asset ManagementSell-1,687,94110,500$724,290
Q2 2025Sequoia Financial AdvisorsBuy2,82547,730$3,292,414
Q2 2025Hillman Value FundSell-7,45392,997$6,414,933
Q2 2025Renaissance Technologies LLCBuy532,853582,853$40,205,200
Q2 2025Ariel Appreciation FundBuy144,5411,164,574$80,332,315
Q2 2025Hancock Classic ValueSell-935,52116,746,853$1,155,197,920
Q2 2025Cullen Value FundSell-4,72411,873$818,986

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.